semaglutide and neuropathy A recent Veterans Health Administration–based target trial emulation evaluated the incidence of nonarteritic anterior ischemic optic (NAION) among adults with type 2 diabetes initiating compared with those initiating an SGLT2 A comment on: “Risk of

Stomach paralysis or gastroparesis is another side effect linked to GLP-1 drugs

The study involved a population with early-stage Alzheimers disease, but with a low proportion of diabetes and obesity

The second and third modifications address clearance and stability

To explain the similarities and differences in the phenotypic characteristics associated with DS, a gene dose imbalance theory has been hypothesized stating that patients with DS have an increased dose or number of gene copies on Hsa21, which may lead to increased gene expression

Abemaciclib is an oral cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitor, approved by the US FDA for treating HR+/HER2- advanced breast cancer

10.1038/nrendo.2015.51 66